CERo Therapeutics Holdings, Inc. (CERO)
NASDAQ: CERO · IEX Real-Time Price · USD
1.390
-0.020 (-1.42%)
At close: Apr 26, 2024, 3:59 PM
1.340
-0.050 (-3.60%)
After-hours: Apr 26, 2024, 6:54 PM EDT
CERO Market Cap
CERO has a market cap or net worth of $20.17 million as of April 26, 2024. Its market cap has decreased by -72.22% in one year.
Market Cap
20.17M
Enterprise Value
13.19M
1-Year Change
-72.22%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since October 6, 2021, CERO's market cap has decreased from $205.90M to $20.17M, a decrease of -90.20%. That is a compound annual growth rate of -59.74%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2024 | 20.80M | -2.80% |
Apr 24, 2024 | 21.40M | 7.54% |
Apr 23, 2024 | 19.90M | -4.78% |
Apr 22, 2024 | 20.90M | -5.43% |
Apr 19, 2024 | 22.10M | -2.64% |
Apr 18, 2024 | 22.70M | -6.97% |
Apr 17, 2024 | 24.40M | -8.27% |
Apr 16, 2024 | 26.60M | 3.10% |
Apr 15, 2024 | 25.80M | -1.53% |
Apr 12, 2024 | 26.20M | -4.73% |
Apr 11, 2024 | 27.50M | -4.84% |
Apr 10, 2024 | 28.90M | -6.17% |
Apr 9, 2024 | 30.80M | 9.61% |
Apr 8, 2024 | 28.10M | 9.77% |
Apr 5, 2024 | 25.60M | -10.49% |
Apr 4, 2024 | 28.60M | -2.72% |
Apr 3, 2024 | 29.40M | -9.54% |
Apr 2, 2024 | 32.50M | -1.52% |
Apr 1, 2024 | 33.00M | -9.84% |
Mar 28, 2024 | 36.60M | 88.66% |
Mar 27, 2024 | 19.40M | -5.37% |
Mar 26, 2024 | 20.50M | -2.84% |
Mar 25, 2024 | 21.10M | -14.23% |
Mar 22, 2024 | 24.60M | -5.02% |
Mar 21, 2024 | 25.90M | -0.38% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NKGen Biotech | 28.88M |
Streamline Health Solutions | 28.77M |
Lipocine | 28.71M |
Pluri | 28.67M |
Cue Health | 28.53M |
Allarity Therapeutics | 28.42M |
Serina Therapeutics | 27.86M |
Acurx Pharmaceuticals | 27.63M |